• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

循环组织因子水平与抗磷脂综合征相关血栓形成的风险。

Circulating levels of tissue factor and the risk of thrombosis associated with antiphospholipid syndrome.

机构信息

Hematology and Hemotherapy Center, University of Campinas, Brazil.

Department of Clinical Medicine, Faculty of Medical Sciences, University of Campinas, Brazil.

出版信息

Thromb Res. 2018 Nov;171:114-120. doi: 10.1016/j.thromres.2018.09.058. Epub 2018 Sep 25.

DOI:10.1016/j.thromres.2018.09.058
PMID:30278301
Abstract

The mechanisms behind the severe hypercoagulable state in antiphospholipid syndrome (APS) have not yet been fully elucidated. Knowledge on the etiology of thrombosis in APS is needed to improve treatment. We performed a case control study to evaluate the association of the levels of circulating tissue factor (TF) with thrombotic APS and unprovoked venous thromboembolism (VTE), as compared with controls without a history of thrombosis. Study participants were selected in the same geographic area. Linear regression was used to evaluate possible determinants of TF levels among controls and logistic regression was used to evaluate the association between TF, unprovoked VTE and t-APS. TF levels were grouped into three categories based on: below 50th percentile [reference], between 50-75th percentiles [second category] and 75th percentile [third category]. Two hundred and eighty participants were included in the study; 51 patients with unprovoked VTE, 111 patients with t-APS and 118 control individuals. The levels of TF were not associated with an increased risk of unprovoked VTE, as compared with controls. The adjusted odds ratio for t-APS was 2.62 (95%CI 1.03 to 6.62) with TF levels between 50-75th percentiles and 8.62 (95%CI 3.76 to 19.80) with TF levels above the 75th percentile, as compared with the reference category (below the 50th percentile). In the subgroup analysis, higher levels of TF were associated with both arterial and venous thrombosis in APS and with both primary and secondary APS. Circulating TF is associated with thrombotic complications related to APS, but not with the risk of unprovoked VTE.

摘要

抗磷脂综合征(APS)严重高凝状态的机制尚未完全阐明。为了改善治疗效果,我们需要了解 APS 中血栓形成的病因。我们进行了一项病例对照研究,以评估循环组织因子(TF)水平与血栓性 APS 和无诱因静脉血栓栓塞症(VTE)的相关性,并与无血栓形成史的对照组进行比较。研究参与者是在同一地理区域选择的。我们使用线性回归来评估对照组中 TF 水平的可能决定因素,使用逻辑回归来评估 TF、无诱因 VTE 和 t-APS 之间的关联。根据以下标准将 TF 水平分为三组:低于第 50 百分位[参考]、第 50-75 百分位[第二组]和第 75 百分位[第三组]。本研究共纳入 280 名参与者;51 名无诱因 VTE 患者、111 名 t-APS 患者和 118 名对照个体。与对照组相比,TF 水平与无诱因 VTE 的风险增加无关。TF 水平在第 50-75 百分位的 t-APS 的调整比值比为 2.62(95%CI 1.03 至 6.62),TF 水平高于第 75 百分位的 t-APS 的调整比值比为 8.62(95%CI 3.76 至 19.80),与参考组(低于第 50 百分位)相比。在亚组分析中,TF 水平升高与 APS 中的动脉和静脉血栓形成以及原发性和继发性 APS 均相关。循环 TF 与与 APS 相关的血栓并发症相关,但与无诱因 VTE 的风险无关。

相似文献

1
Circulating levels of tissue factor and the risk of thrombosis associated with antiphospholipid syndrome.循环组织因子水平与抗磷脂综合征相关血栓形成的风险。
Thromb Res. 2018 Nov;171:114-120. doi: 10.1016/j.thromres.2018.09.058. Epub 2018 Sep 25.
2
Expression of tissue factor mRNA in thrombosis associated with antiphospholipid syndrome.组织因子 mRNA 在与抗磷脂综合征相关的血栓形成中的表达。
J Thromb Thrombolysis. 2021 Feb;51(2):370-378. doi: 10.1007/s11239-020-02209-1.
3
Thrombosis in primary antiphospholipid syndrome: a pivotal role for monocyte tissue factor expression.原发性抗磷脂综合征中的血栓形成:单核细胞组织因子表达的关键作用。
Arthritis Rheum. 1997 May;40(5):834-41. doi: 10.1002/art.1780400509.
4
Differences in plasma fibrin clot composition in patients with thrombotic antiphospholipid syndrome compared with venous thromboembolism.血栓性抗磷脂综合征与静脉血栓栓塞患者血浆纤维蛋白凝块组成的差异。
Sci Rep. 2018 Nov 23;8(1):17301. doi: 10.1038/s41598-018-35034-x.
5
The role of the tissue factor pathway in the hypercoagulable state in patients with the antiphospholipid syndrome.组织因子途径在抗磷脂综合征患者高凝状态中的作用。
Thromb Haemost. 1998 Feb;79(2):276-81.
6
The relationship between mean platelet volume and thrombosis recurrence in patients diagnosed with antiphospholipid syndrome.抗磷脂综合征患者平均血小板体积与血栓形成复发之间的关系。
Rheumatol Int. 2014 Nov;34(11):1599-605. doi: 10.1007/s00296-014-2996-0. Epub 2014 Mar 27.
7
Plasma microparticle tissue factor activity in patients with antiphospholipid antibodies with and without clinical complications.抗磷脂抗体阳性伴或不伴临床并发症患者的血浆微粒体组织因子活性。
Thromb Res. 2014 Feb;133(2):187-9. doi: 10.1016/j.thromres.2013.11.027. Epub 2013 Dec 1.
8
Altered fibrin clot structure/function in patients with antiphospholipid syndrome: association with thrombotic manifestation.抗磷脂综合征患者纤维蛋白凝块结构/功能改变:与血栓表现相关。
Thromb Haemost. 2014 Aug;112(2):287-96. doi: 10.1160/TH13-11-0980. Epub 2014 Mar 20.
9
Rivaroxaban limits complement activation compared with warfarin in antiphospholipid syndrome patients with venous thromboembolism.利伐沙班与华法林相比可限制抗磷脂综合征伴静脉血栓栓塞患者的补体激活。
J Thromb Haemost. 2016 Nov;14(11):2177-2186. doi: 10.1111/jth.13475. Epub 2016 Sep 30.
10
Associations between complement pathways activity, mannose-binding lectin, and odds of unprovoked venous thromboembolism.补体途径活性、甘露糖结合凝集素与特发性静脉血栓栓塞症发生风险的相关性。
Thromb Res. 2018 Sep;169:50-56. doi: 10.1016/j.thromres.2018.06.019. Epub 2018 Jun 30.

引用本文的文献

1
A novel update on vitamin D in recurrent pregnancy loss (Review).关于复发性妊娠丢失中维生素 D 的最新研究进展(综述)。
Mol Med Rep. 2021 May;23(5). doi: 10.3892/mmr.2021.12021. Epub 2021 Mar 24.
2
Expression of tissue factor mRNA in thrombosis associated with antiphospholipid syndrome.组织因子 mRNA 在与抗磷脂综合征相关的血栓形成中的表达。
J Thromb Thrombolysis. 2021 Feb;51(2):370-378. doi: 10.1007/s11239-020-02209-1.
3
Immunomodulatory Effects of Vitamin D in Pregnancy and Beyond.维生素 D 在妊娠及妊娠以外时期的免疫调节作用
Front Immunol. 2019 Nov 22;10:2739. doi: 10.3389/fimmu.2019.02739. eCollection 2019.